SCHEMBL27346582

SCHEMBL27346582

Cc1nc(C(F)(F)F)ccc1[S+]([O-])N1CC2CN(CC34CCOC(C)(C3)C4)CC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26065198 0.86 — —
SCHEMBL27346583 0.81 TRPV4 (0.40) —
SCHEMBL30719473 0.81 TRPV4 (0.40) —
SCHEMBL27346597 0.81 KCNH2 (0.30) —
SCHEMBL26065174 0.77 — —
SCHEMBL26065199 0.72 TRPV4 (0.37) —
SCHEMBL27346630 0.71 — —
SCHEMBL27346602 0.71 TRPV4 (0.41) —
SCHEMBL27346641 0.71 TRPV4 (0.41) —
SCHEMBL25370981 0.71 TRPV4 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024015503-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2024-01-18 — — WO disclosed
Send feedback